Lamotrigine — Drug Intelligence | 3 EU Trials

Filter these 3 trials by condition, phase, country and more.

3 Registered trials

1 Recruiting

1 Completed trials

5 Sponsors

5 Countries

Phase III

Phase IV

Phase III: 2 Phase IV: 1

Oversight events:

2 temporary halts 1 corrective measure across 1 trial

Indications tested

3 total

A randomised, controlled trial to investigate the effect of a four/six week intensified pharmacological treatment for schizophrenia, major d… Not authorised

2022-502185-24-00 Phase III 4 countries University Medical Center Utrecht
The LiLa-Bipolar RCT Recruiting

2023-509607-32-00 Phase IV 1 country Frederiksberg Hospital; Region Hovedstaden
Efficacy and Tolerability of AP707 in Patients with chronic pain due to central Neuropathy of any Genesis Ended

2022-500899-66-00 Phase III 2 countries Apurano Pharmaceuticals GmbH; Cannaxan GmbH

Showing 1–3 of 3 trials